Pay in 4 interest-free payments of $5.60 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Foundayo (orforglipron), developed by Eli Lilly, is a new, once-daily oral GLP-1 weight-loss pill approved in the UAE (second globally after the US) and expected to be available from May 2026
The REDEFINE 2 trial examined the combination in adults with type 2 diabetes, where weight loss is typically harder to achieve due to insulin resistance and medication effects
It modulates nitric oxide pathways, counters oxidative stress, and exhibits anti-inflammatory effects without reported toxicity in research settings
GLOW Blend (BPC-157 + TB-500 + GHK-Cu) What it is: A beauty-focused regenerative blend that promotes skin renewal, hair health, collagen production, and recovery
Add your phone number below to get health updates and exclusive VIP offers
US$ 25.50
US$ 29.29
US$ 28.85
US$ 22.23
US$ 24.32
